Telomir Pharmaceuticals holds annual shareholder meeting
TELO•Annual shareholder meeting results
Telomir Pharmaceuticals held its 2026 annual shareholder meeting on Sept. 11, 2026.
Shareholders backed the appointment of Salberg & Company, P.A. as independent auditor for the year ending Dec. 31, 2026.
Votes also supported selecting four directors to serve until the next annual meeting.
Investors authorized an adjournment if needed to solicit additional proxies to secure support for the director slate and auditor item.
